Abstract
The term «glaucoma» unites a large group of eye diseases of various origins with a progradient, chronic course. The aim of this study was to study the neuroprotective effect of Cytoflavin in patients with POAG with normalized IOP based on the clinical and functional parameters of the organ of vision. Material and methods. The study involved 60 patients diagnosed with primary open-angle glaucoma (POAG) stage I, II and III. All patients were divided into 2 groups depending on the treatment received. Results. Cytoflavin has a pronounced neuroprotective effect in POAG, effectively protecting the nervous tissue and slowing down apoptosis. In addition to improving the clinical and functional indicators of the organ of vision, we noted an improvement in overall well-being, attention and overall performance in all patients. Conclusions. Analysis of the obtained results indicates a rather high clinical efficacy of Cytoflavin in the conservative treatment of patients with POAG with compensated IOP and can be recommended as a background neuroprotective therapy. Keywords: primary open-angle glaucoma, neuroprotective treatment, Cytoflavin, visual functions, glaucoma process
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
